103 related articles for article (PubMed ID: 11407901)
1. Primary adult human astrocytes as an ex vivo vehicle for beta-glucuronidase delivery in the brain.
Serguera C; Sarkis C; Ridet JL; Colin P; Moullier P; Mallet J
Mol Ther; 2001 Jun; 3(6):875-81. PubMed ID: 11407901
[TBL] [Abstract][Full Text] [Related]
2. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model.
Lundberg C; Horellou P; Mallet J; Björklund A
Exp Neurol; 1996 May; 139(1):39-53. PubMed ID: 8635567
[TBL] [Abstract][Full Text] [Related]
3. Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system.
Buchet D; Serguera C; Zennou V; Charneau P; Mallet J
Mol Cell Neurosci; 2002 Mar; 19(3):389-401. PubMed ID: 11906211
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo and in vitro studies of transgene expression in rat astrocytes transduced with lentiviral vectors.
Ericson C; Wictorin K; Lundberg C
Exp Neurol; 2002 Jan; 173(1):22-30. PubMed ID: 11771936
[TBL] [Abstract][Full Text] [Related]
5. Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes.
Selkirk SM; Greenberg SJ; Plunkett RJ; Barone TA; Lis A; Spence PO
Gene Ther; 2002 Apr; 9(7):432-43. PubMed ID: 11938458
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
7. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice.
Kosuga M; Sasaki K; Tanabe A; Li XK; Okawa H; Ogino I; Okuda O; Arai H; Sakuragawa N; Kamata Y; Azuma N; Suzuki S; Yamada M; Okuyama T
Mol Ther; 2001 Feb; 3(2):139-48. PubMed ID: 11237670
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of human adult astrocytes: efficiency and safety requirements for an autologous gene therapy.
Ridet JL; Sarkis C; Serguera C; Zennou V; Charneau P; Mallet J
J Neurosci Res; 2003 Jun; 72(6):704-8. PubMed ID: 12774310
[TBL] [Abstract][Full Text] [Related]
10. Widespread distribution of adenovirus-transduced monkey amniotic epithelial cells after local intracerebral injection: implication for cell-mediated therapy for lysosome storage disorders.
Kosuga M; Takahashi S; Tanabe A; Fujino M; Li XK; Suzuki S; Yamada M; Kakishita K; Ono F; Sakuragawa N; Okuyama T
Cell Transplant; 2001; 10(4-5):435-9. PubMed ID: 11549068
[TBL] [Abstract][Full Text] [Related]
11. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
McKie EA; Graham DI; Brown SM
Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
[TBL] [Abstract][Full Text] [Related]
12. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
Kügler S; Kilic E; Bähr M
Gene Ther; 2003 Feb; 10(4):337-47. PubMed ID: 12595892
[TBL] [Abstract][Full Text] [Related]
13. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease.
Bankiewicz KS; Leff SE; Nagy D; Jungles S; Rokovich J; Spratt K; Cohen L; Libonati M; Snyder RO; Mandel RJ
Exp Neurol; 1997 Mar; 144(1):147-56. PubMed ID: 9126164
[TBL] [Abstract][Full Text] [Related]
14. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
15. Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo.
Gerdes CA; Castro MG; Löwenstein PR
Mol Ther; 2000 Oct; 2(4):330-8. PubMed ID: 11020348
[TBL] [Abstract][Full Text] [Related]
16. Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes.
Ridet JL; Corti O; Pencalet P; Hanoun N; Hamon M; Philippon J; Mallet J
Hum Gene Ther; 1999 Jan; 10(2):271-80. PubMed ID: 10022551
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
18. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.
Ghodsi A; Stein C; Derksen T; Martins I; Anderson RD; Davidson BL
Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
20. Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
Do Thi NA; Saillour P; Ferrero L; Paunio T; Mallet J
Gene Ther; 2007 Mar; 14(5):441-50. PubMed ID: 17093508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
